These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35140138)

  • 1. Clinical practice guideline for the management of paediatric Charcot-Marie-Tooth disease.
    Yiu EM; Bray P; Baets J; Baker SK; Barisic N; de Valle K; Estilow T; Farrar MA; Finkel RS; Haberlová J; Kennedy RA; Moroni I; Nicholson GA; Ramchandren S; Reilly MM; Rose K; Shy ME; Siskind CE; Yum SW; Menezes MP; Ryan MM; Burns J
    J Neurol Neurosurg Psychiatry; 2022 May; 93(5):530-538. PubMed ID: 35140138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Falls in paediatric Charcot-Marie-Tooth disease: a 6-month prospective cohort study.
    Kennedy RA; Carroll K; Hepworth G; Paterson KL; Ryan MM; McGinley JL
    Arch Dis Child; 2019 Jun; 104(6):535-540. PubMed ID: 30104392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of muscle cramps in Charcot-Marie-tooth disease.
    Johnson NE; Sowden J; Dilek N; Eichinger K; Burns J; Mcdermott MP; Shy ME; Herrmann DN
    Muscle Nerve; 2015 Apr; 51(4):485-8. PubMed ID: 25042364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
    Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
    J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Consensus Statement on the Surgical Treatment of Charcot-Marie-Tooth Disease.
    Pfeffer GB; Gonzalez T; Brodsky J; Campbell J; Coetzee C; Conti S; Guyton G; Herrmann DN; Hunt K; Johnson J; McGarvey W; Pinzur M; Raikin S; Sangeorzan B; Younger A; Michalski M; An T; Noori N
    Foot Ankle Int; 2020 Jul; 41(7):870-880. PubMed ID: 32478578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.
    Gess B; Baets J; De Jonghe P; Reilly MM; Pareyson D; Young P
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011952. PubMed ID: 26662471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foot surgery for adults with Charcot-Marie-Tooth disease.
    Laurá M; Barnett J; Benfield J; Ramdharry GM; Welck MJ
    Pract Neurol; 2024 Jul; 24(4):275-284. PubMed ID: 38631902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
    Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
    J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2nd Workshop of the European CMT Consortium: 53rd ENMC International Workshop on Classification and Diagnostic Guidelines for Charcot-Marie-Tooth Type 2 (CMT2-HMSN II) and Distal Hereditary Motor Neuropathy (distal HMN-Spinal CMT) 26-28 September 1997, Naarden, The Netherlands.
    Neuromuscul Disord; 1998 Aug; 8(6):426-31. PubMed ID: 9713862
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale.
    Zuccarino R; Prada V; Moroni I; Pagliano E; Foscan M; Robbiano G; Pisciotta C; Cornett K; Shy R; Schenone A; Pareyson D; Shy M; Burns J
    J Peripher Nerv Syst; 2020 Jun; 25(2):138-142. PubMed ID: 32394473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
    Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
    JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait in children and adolescents with Charcot-Marie-Tooth disease: a systematic review.
    Kennedy RA; Carroll K; McGinley JL
    J Peripher Nerv Syst; 2016 Dec; 21(4):317-328. PubMed ID: 27513454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.
    Sivera Mascaró R; García Sobrino T; Horga Hernández A; Pelayo Negro AL; Alonso Jiménez A; Antelo Pose A; Calabria Gallego MD; Casasnovas C; Cemillán Fernández CA; Esteban Pérez J; Fenollar Cortés M; Frasquet Carrera M; Gallano Petit MP; Giménez Muñoz A; Gutiérrez Gutiérrez G; Gutiérrez Martínez A; Juntas Morales R; Ciano-Petersen NL; Martínez Ulloa PL; Mederer Hengstl S; Millet Sancho E; Navacerrada Barrero FJ; Navarrete Faubel FE; Pardo Fernández J; Pascual Pascual SI; Pérez Lucas J; Pino Mínguez J; Rabasa Pérez M; Sánchez González M; Sotoca J; Rodríguez Santiago B; Rojas García R; Turon-Sans J; Vicent Carsí V; Sevilla Mantecón T
    Neurologia (Engl Ed); 2024 Mar; ():. PubMed ID: 38431252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease.
    Aboussouan LS; Lewis RA; Shy ME
    Lung; 2007; 185(1):1-7. PubMed ID: 17294338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.
    Mannil M; Solari A; Leha A; Pelayo-Negro AL; Berciano J; Schlotter-Weigel B; Walter MC; Rautenstrauss B; Schnizer TJ; Schenone A; Seeman P; Kadian C; Schreiber O; Angarita NG; Fabrizi GM; Gemignani F; Padua L; Santoro L; Quattrone A; Vita G; Calabrese D; ; Young P; Laurà M; Haberlová J; Mazanec R; Paulus W; Beissbarth T; Shy ME; Reilly MM; Pareyson D; Sereda MW
    Neuromuscul Disord; 2014 Nov; 24(11):1003-17. PubMed ID: 25085517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Charcot-Marie-Tooth disease.
    Jani-Acsadi A; Ounpuu S; Pierz K; Acsadi G
    Pediatr Clin North Am; 2015 Jun; 62(3):767-86. PubMed ID: 26022174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.